Ampio pharmaceuticals strengthens management team and board of directors

Englewood, colo., oct. 13, 2021 /prnewswire/ -- ampio pharmaceuticals (nyse american: ampe), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammatory conditions, today announced the appointments of howard levy, m.b.b.ch.
AMPE Ratings Summary
AMPE Quant Ranking